Approach to the patient with the first episode of nephrolithiasis

Clinical Reviews in Bone and Mineral Metabolism

Volumn 2, Issue 3, 2004, Pages 265-278

  Cameron, Mary Ann ^a   Pak, Charles Y C ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Diagnosis; Medical therapy; Renal stone disease

Indexed keywords

ALLOPURINOL; ASCORBIC ACID; CALCIUM; CARBONATE DEHYDRATASE INHIBITOR; CITRATE POTASSIUM; CITRIC ACID; CORTICOSTEROID; FUROSEMIDE; INDAPAMIDE; INDINAVIR; OXALIC ACID; SILICON DIOXIDE; THIAZIDE DIURETIC AGENT; TRIAMTERENE; VITAMIN D;

ABNORMAL URINE COMPOSITION; CALCIUM INTAKE; CLINICAL TRIAL; DRUG MEGADOSE; FAMILY HISTORY; HUMAN; HYDRATION; HYPERCALCIURIA; HYPEROXALURIA; HYPOCITRATURIA; HYPOKALEMIA; KIDNEY COLIC; NEPHROLITHIASIS; PROTEIN RESTRICTION; RADIODIAGNOSIS; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT; SODIUM RESTRICTION; URINE PH; UROLITHIASIS;

EID: 26244460711     PISSN: 15348644     EISSN: None     Source Type: Journal    
DOI: 10.1385/BMM:2:3:265     Document Type: Review

References (60)

1. Stamatelou K, Francis ME, Jones CA, Nyberg LM, Curhan GC. 2003 Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int 63:1817-1823.
2. Shuster J, Scheaffer RL. 1984 Economic impact of kidney stones in white male adults. Urology 24:327-331.
3. Trinchieri A, Ostini F, Nespoli R, Rovera F, Montanari E, Zanetti G. 1999 A prospective study of recurrence rate and risk factors for recurrence after a first renal stone. J Urol 162:27-30.
4. Strauss AL, Coe FL, Deutsch L, Parks JH. 1982 Factors that predict relapse of calcium nephrolithiasis during treatment: a prospective study. Am J Med 72:17-24.
5. Uribarri J, Oh MS, Carroll HJ. 1989 The first kidney stone. Ann Intern Med 111:1006-1009.
6. Pak CY. 1982 Should patients with single renal stone occurrence undergo diagnostic evaluation? J Urol 127:855-858.
7. Ljunghall S. 1979 Family history of renal stones in a population study of stone-formers and health subjects. Br J Urol 51:249-252.
8. Pak CYC. 1997 Medical management of nephrolithiasis - a new simplified approach for general practice. Am J Med Sci 313:215-219.
9. Pak CYC, Poindexter JR, Adams-Huet B, Pearle MS. 2003 Predictive value of kidney stone composition in the detection of metabolic abnormalities. Am J Med 115:26-32.
10. Pak CYC, Asplin JR, Ogawa Y, Resnick MI, Rodgers AL, Traxer O. 2001 Evaluation of stone-forming patients. Paris Consultation on Stone Disease. Paris, France.
11. Petritsch PH, Schwarz R. 1978 Urinary calculous disease in childhood. Urology 12:407-410.
12. Curhan GC, Willett WC, Rimm EB, Stampfer MJ. 1997 Family history and risk of kidney stones. J Am Soc Nephrol 8:1568-1573.
13. Pak CY, Sakhaee K, Crowther C, Brinkley L. 1980 Evidence justifying a high fluid intake in treatment of nephrolithiasis. Ann Intern Med 93:36-39.
14. Parks JH, Worcester EM, O'Connor RC, Coe FL. 2003 Urine stone risk factors in nephrolithiasis patients with and without bowel disease. Kidney Int 63:255-265.
15. Klugman V, Pak CYC, Favus MJ. 2001 Nephrolithiasis in primary hyperparathyroidism, in The Parathyroids: Basic and Clinical Concepts, Bilezikian JP, Levine MR, eds, Academic Press, San Diego, CA, pp. 437-450.
16. Hwang TI, Hill K, Schneider V, Pak CYC. 1988 Effect of prolonged bedrest on propensity for renal stone formation. J Clin Endocrinol Metab 66:109-112.
17. Muther RS, McCarron DA, Bennett WM. 1981 Renal manifestations of sarcoidosis. Arch Intern Med 141:643-645.
18. Maalouf N, Cameron MA, Moe OW, Sakhaee K. 2004 Novel insights into the pathogenesis of uric acid nephrolithiasis. Curr Opin Nephrol Hypertens 13:181-189.
19. Abate N, Chandalia M, Cabo-Chan AV, Moe OW, Sakhaee K. 2004 The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int 65:386-392.
20. Maalouf N, Sakhaee K, Parks JH, Coe FL, Adams-Huet B, Pak CYC. 2004 Association of urinary pH with body weight in nephrolithiasis. Kidney Int 65:1422-1425.
21. Pak CYC, Sakhaee K, Moe OW, et al. 2003 Biochemical profile of stone-forming patients with diabetes mellitus. Urology 61:523-527.
22. Curhan GC, Willett WC, Rimm EB, Stampfer MJ. 1993 A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. New Engl J Med 328:833-838.
23. Traxer O, Huet B, Poindexter JR, Pak CYC, Pearle MS. 2003 Effect of ascorbic acid consumption on urinary stone risk factors. J Urol 170:397-401.
24. Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Giannini A. 1996 Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol 155:839-843.
25. Sakhaee K, Harvey JA, Padalino PK, Whitson P, Pak CY. 1993 The potential role of salt abuse on the risk for kidney stone formation. J Urol 150:310-312.
26. Reddy ST, Wang CY, Sakhaee K, Brinkley L, Pak CYC. 2002 Effect of low-carbohydrate high-protein diets on acid-base balance, stone-forming propensity, and calcium metabolism. Am J Kidney Dis 40:265-274.
27. Wabner CL, Pak CYC. 1993 Effect of orange juice consumption on urinary stone risk factors. J Urol 149:1405-1408.
28. Holmes RP, Goodman HO, Assimos DG. 2001 Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int 59:270-276.
29. Tiselius HG, Larsson L. 1993 Calcium phosphate: an important crystal phase in patients with recurrent calcium stone formation? Urol Res 21:175-180.
30. Mandel N, Mandel I, Fryjoff K, Rejniak T, Mandel G. 2003 Conversion of calcium oxalate to calcium phosphate with recurrent stone episodes. J Urol 169:2026-2029.
31. Leusmann DB, Niggemann H, Roth S, von Ahlen H. 1995 Recurrence rates and severity of urinary calculi. Scand J Urol Nephrol 29:279-283.
32. Pak CYC, Poindexter JR, Peterson RD, Heller HJ. 2004 Biochemical and physicochemical presentations of patients with brushite stones. J Urol 171:1046-1049.
33. Zhong P, Preminger GM. 1994 Mechanisms of differing stone fragility in extrcorporeal shockwave lithotripsy. J Endourol 8:263-268.
34. Ramakumar S, Patterson DE, LeRoy AJ, et al. 1999 Prediction of stone composition from plain radiographs: A prospective study. J Endourol 13:397-401.
35. Grampsas SA, Chandhoke PS, Fan J, et al. 2000 Anatomic and metabolic risk factors for nephrolithiasis in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis 36:53-57.
36. Levine JA, Neitlich J, Verga M, Dalrymple N, Smith RC. 1997 Ureteral calculi in patients with flank pain: correlation of plain radiography with unenhanced helical CT. Radiology 204:27-31.
37. Preminger GM, Vieweg J, Leder RA, Nelson RC. 1998 Urolithiasis: detection and management with unenhanced spiral CT - A urologic perspective. Radiology 207:308-309.
38. Portis AJ, Sundaram CP. 2001 Diagnosis and initial management of kidney stones. Am Fam Physician 63:1329-1338.
39. Pak CYC, Resnick MI. 2000 Medical therapy and new approaches to management of urolithiasis. Urol Clin North Am 27:243-253.
40. Pak CYC, Peterson R, Poindexter JR. 2001 Adequacy of a single stone risk analysis in the medical evaluation of urolithiasis. J Urol 165:378-381.
41. Pak CYC, Skurla C, Harvey J. 1985 Graphic display of urinary risk factors for renal stone formation. J Urol 134:867-870.
42. Maalouf N, Pak CYC. 2004 Nephrolithiasis, in Clinical Nephrology, Dialysis, and Transplantation, Malluche HH, Sawaya BP, Hakim RM, Sayegh MH eds, Dustri-Verlag Inc, Rockledge, FL
43. Kocvara R, Plasgura P, Petrik A, Louzensky G, Bartonickova K, Dvoracek J. 1999 A prospective study of nonmedical prophylaxis after a first kidney stone. BJU Int 84:393-398.
44. Borghi L, Schianchi T, Meschi T, et al. 2002 Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. New Engl J Med 346:77-84.
45. Frank M, DeVries A, Lazebnik J, Kochwa S. 1959 Epidemiological investigations of urolithiasis in Israel. J Urol 81:497-504.
46. Curhan GC, Willett WC, Speizer FE, Stampfer MJ. 1998 Beverage use and risk for kidney stones in women. Ann Intern Med 128:534-540.
47. Curhan GC, Willett WC, Rimm EB, Spiegelman D, Stampfer MJ. 1996 Prospective study of beverage use and the risk of kidney stones. Am J Epidemiol 143:240-247.
48. Breslau NA, Brinkley L, Hill KD, Pak CY. 1998 Relationship of animal protein-rich diet to kidney stone formation and calcium metabolism. J Clin Endocrinol Metab 66:140-146.
49. Amanzadeh J, Gitomer WL, Zerwekh JE, et al. 2003 Effect of high protein diet on stone-forming propensity and bone loss in rats. Kidney Int 64:2142-2149.
50. Hiatt RA, Ettinger B, Caan B, Quesenberry CP Jr., Duncan D, Citron JT. 1996 Randomized controlled trial of a low animal protein, high fiber diet in the prevention of recurrent calcium oxalate kidney stones. Am J Epidemiol 144:25-33.
51. Pak CYC, Ohata M, Lawrence EC, Snyder W. 1974 The hypercalciurias: causes, parathyroid functions, and diagnostic criteria. J Clin Invest 54:387-400.
52. Siener R, Ebert D, Nicolay C, Hesse A. 2003 Dietary risk factors for hyperoxaluria in calcium oxalate stone formers. Kidney Int 63:1037-1043.
53. Yagisawa T, Chandhoke PS, Fan J. 1998 Metabolic risk factors in patients with first-time and recurrent stone formations as determined by comprehensive metabolic evaluation. Urology 52:750-755.
54. Aruga S, Wehrli S, Kaissling B, et al. 2000 Chronic metabolic acidosis increases NaDC-1 mRNA and protein abundance in rat kidney. Kidney Int 58:206-215.
55. De Ferrari ME, Macaluso M, Brunati C, Pozzoli R, Colussi G. 1996 Hypocitraturia and Ureaplasma urealyticum urinary tract infection in patients with idiopathic calcium nephrolithiasis. Nephrol Dial Transplant 11:1185.
56. Nicar M, Peterson R, Pak CYC. 1984 Use of potassium citrate as potassium supplement during thiazide therapy of calcium nephrolithiasis. J Urol 131:430-433.
57. Pak CY, Fuller CJ, Sakhaee K, Preminger GM, Britton F. 1985 Long-term treatment of calcium nephrolithiasis with potassium citrate. J Urol 134:11-19.
58. Pak CY, Waters O, Arnold L, Holt K, Cox C, Barilla D. 1977 Mechanism for calcium urolithiasis among patients with hyperuricosuria. J Clin Invest 59:426-431.
59. Ettinger B, Tang A, Citron JT, Livermore B, Williams T. 1986 Randomized trial of allopurinol in the prevention of calcium oxalate calculi. New Engl J Med 315:1386-1389.
60. Fellstrom B, Danielson BG, Karlstrom B, Lithell H, Ljunghall S, Vessby B. 1983 The influence of a high dietary intake of purine-rich animal protein on urinary urate excretion and supersaturation in renal stone disease. Clin Sci 64:399-405.